Ketoconazole Flush

Verify with FDA CVM →

49 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
49
Total Reports
2
Deaths Reported
410.0%
Death Rate

Active Ingredients

Ketoconazole Flush

Administration Routes

UnknownAuricular (Otic)Intra-Articular

Species Affected

Dog 41
Cat 8

Most Affected Breeds

Retriever - Labrador 6
Crossbred Canine/dog 6
Retriever - Golden 4
Domestic Shorthair 4
Terrier - Yorkshire 2
Poodle - Standard 2
Dog (unknown) 2
Domestic Mediumhair 2
Pit Bull 2
Rottweiler 1

Most Reported Reactions

Lack of efficacy - NOS 15
Otorrhoea 10
Ataxia 9
Ear infection NOS 7
Head tilt - ear disorder 7
Head shake - ear disorder 6
Ear discharge 5
Deafness 5
Lethargy (see also Central nervous system depression in 'Neurological') 5
Horner's syndrome 5
Ear pruritus 5
Keratoconjunctivitis sicca 4

Outcome Breakdown

Outcome Unknown
36 (73.5%)
Recovered/Normal
9 (18.4%)
Died
1 (2.0%)
Euthanized
1 (2.0%)
Recovered with Sequela
1 (2.0%)
Ongoing
1 (2.0%)

Data Summary

Metric Value
Total adverse event reports 49
Reports involving death 2
Case-fatality rate (reported events) 410.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ketoconazole Flush Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 49 adverse event reports referencing Ketoconazole Flush, including 2 reports in which the animal died — a 410.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ketoconazole Flush. Reported administration routes include Unknown, Auricular (Otic), Intra-Articular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ketoconazole Flush reports are Dog (41 reports), Cat (8 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (6), Crossbred Canine/dog (6), Retriever - Golden (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ketoconazole Flush are Lack of efficacy - NOS (15), Otorrhoea (10), Ataxia (9), Ear infection NOS (7). Of the 49 reports with a coded outcome, Outcome Unknown is the leading category at 73.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ketoconazole Flush.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial